Who
Jeffrey S. Ervin
CFO
Company insider
Files Form 4 as: CFO, Allarity Therapeutics; Director, Cingulate; Chief Executive Officer, IMAC Holdings.
In numbers
- Trades disclosed
- 28
- Buys
- 4
- Sells
- 0
- Bought
- $7,924
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 22 Feb 2019
- Last trade
- 28 Jan 2026
- Last filed
- 30 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jan 2026filed 30 Apr 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 28 Jan 2026filed 30 Apr 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 20 Jun 2025filed 23 Jun 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 12 Jun 2024filed 13 Jun 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,875 | filing |
| 4 Mar 2024filed 6 Mar 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 21 May 2022filed 25 May 2022 | IMAC Holdingsoption or derivative | SEC FORM 4 Code M | —37,500 at $0.00 | filing |
| 21 May 2022filed 25 May 2022 | IMAC Holdings | SEC FORM 4 Code M | —37,500 | filing |
| 21 May 2021filed 21 May 2021 | IMAC Holdings | SEC FORM 4 Code M | —37,500 | filing |
| 21 May 2021filed 21 May 2021 | IMAC Holdingsoption or derivative | SEC FORM 4 Code M | —37,500 at $0.00 | filing |
| 10 Sep 2020filed 10 Sep 2020 | IMAC Holdings | SEC FORM 4 Bought | $7701,000 at $0.77 | filing |
| 10 Sep 2020filed 10 Sep 2020 | IMAC Holdings | SEC FORM 4 Bought | $3,1604,000 at $0.79 | filing |
| 21 May 2020filed 26 May 2020 | IMAC Holdingsoption or derivative | SEC FORM 4 Code M | —37,500 at $0.00 | filing |
| 21 May 2020filed 26 May 2020 | IMAC Holdings | SEC FORM 4 Code M | —37,500 | filing |
| 21 May 2020filed 26 May 2020 | IMAC Holdings | SEC FORM 4 Code F | $16K10,000 at $1.61 | filing |
| 3 Apr 2020filed 6 Apr 2020 | IMAC Holdings | SEC FORM 4 Bought | $1,4501,000 at $1.45 | filing |
| 19 Nov 2019filed 20 Nov 2019 | IMAC Holdings | SEC FORM 4 Bought | $212100 at $2.12 | filing |
| 19 Nov 2019filed 20 Nov 2019 | IMAC Holdings | SEC FORM 4 Bought | $633300 at $2.11 | filing |
| 19 Nov 2019filed 20 Nov 2019 | IMAC Holdings | SEC FORM 4 Bought | $223100 at $2.23 | filing |
News
No headline names them, or the companies they trade most, lately.